|
Exosomal cargo | Secreting cell | Recipient cell/patient | Activity | Ref. |
|
DC-exosomes pulsed with functional MHC/peptide molecules | Dendritic cell | Metastatic melanoma patients | Cancer immunotherapy strategy (cancer vaccine) | [28] |
|
DC-derived exosomes loaded with MAGE tumor antigens | Dendritic cell | Advanced non-small cell lung cancer | Cancer immunotherapy strategy (cancer vaccine) | [29] |
|
exosome-delivered siRNA | Deliver tumor suppressors to their target sites by exosomes | Cancer cells | Posttranscriptional gene silencing and apoptotic cell death of targeted cancer cells | [30] |
CMV-delivered miRNA-128 | Glioblastoma | Can affect cancer cell behavior Inhibits Glioma proliferation and self-renewal | [31] |
|
CMV-delivered miRNA-7 | | Glioblastoma | Inhibits the epidermal growth factor receptor and down-regulate the Akt-pathway | [32] |
|
Aex in combination with GM-CSF | Ascites | Advanced colorectal cancer | Used as immunotherapy –tumor specific antitumor cytotoxic T lymphocyte | [33] |
|
mmnResistant anticancer drug-treated HepG2 cells -derived exosomes | Resistant anticancer drug-treated HepG2 cells | Hepatocellular carcinoma | Elicit effective NK-cell antitumor responses in vitro; Vaccine for Hepatocellular carcinoma immunotherapy | [34] |
|
Brain endothelial cell-derived exosomes | Brain endothelial cell | Brain cancer | Can deliver anticancer drugs across the BBB | [35] |
|
List of various types | Refer to the reference | Various | Nanoscale cancer vaccine | [36] |
|
List of tumor suppressive miRNA | Refer to the reference | Various | Tumor suppressive | [37] |
|
Dox-loaded exosomes and Dox-loaded nanovesicles | Cell-derived exosomes (monocytes/macrophages) | Malignant cells | Antitumor | [38] |
|